Z-score analysis, which allows direct comparison across different studies and platforms independently from timescale and range of predictor variables, revealed that LAG3 axis has more influence on the clinical outcome of patients with CLL than in other hematological malignancies (Figure 3C). This evidence concerns the gene LAG3 and B-cell chronic lymphocytic leukemia.